Page 7 - Precision Flow News Today

/PRNewswire/ -- According to Coherent Market Insights, The global nasal cannula market is estimated to account for US$ 10,491.1 Mn in terms of value by the end...

/PRNewswire/ -- According to Coherent Market Insights, The global nasal cannula market is estimated to account for US$ 10,491.1 Mn in terms of value by the end...

SEATTLE, Dec. 22, 2021 /PRNewswire/ -- According to Coherent Market Insights, The global nasal cannula market is estimated to account for US$ 10,491.1 Mn in terms of value by the end of 2028.

Major Shift in Demand For Oxygen Therapy Devices – New Study For 2021 By John Fraser and Kamran Zamanian, Ph.D., iData Research The continual administration of medical oxygen, known as oxygen therapy, is used to treat a variety of medical conditions, such as cancer, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Generally, oxygen therapy devices are used to treat patients who can no longer receive adequate volumes of oxygen through regular breathing and those who require h...

Press release content from Business Wire. The AP news staff was not involved in its creation. Vapotherm to Report First Quarter 2021 Financial Results April 21, 2021 GMT EXETER, N.H.--(BUSINESS WIRE)--Apr 21, 2021-- Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy ® products which are used to treat patients of all ages suffering from respir...

Press release content from Business Wire. The AP news staff was not involved in its creation. Vapotherm to Participate in Fireside Chat at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference February 12, 2021 GMT EXETER, N.H.--(BUSINESS WIRE)--Feb 12, 2021-- Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy...

Posted on 193 Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that it will release financial results for the fourth quarter and fiscal year 2020 after the close of tradi...

Posted on 445 Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced certain preliminary unaudited fourth quarter and full year 2020 revenue results. Preliminary revenue for th...

Press release content from Business Wire. The AP news staff was not involved in its creation. Vapotherm to Present at the 23rd Annual ICR/Westwicke Conference January 7, 2021 GMT EXETER, N.H.--(BUSINESS WIRE)--Jan 7, 2021-- Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering fr...